These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9622271)

  • 21. Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM).
    Brewster LP; Brey EM; Tassiopoulos AK; Xue L; Maddox E; Armistead D; Burgess WH; Greisler HP
    Am J Surg; 2004 Nov; 188(5):575-9. PubMed ID: 15546573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells.
    Cucina A; Borrelli V; Randone B; Coluccia P; Sapienza P; Cavallaro A
    J Surg Res; 2003 Jan; 109(1):16-23. PubMed ID: 12591230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biologic effects of growth factor-toxin conjugates in models of vascular injury depend on dose, mode of delivery, and animal species.
    Yu C; Cunningham M; Rogers C; Dinbergs ID; Edelman ER
    J Pharm Sci; 1998 Nov; 87(11):1300-4. PubMed ID: 9811480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
    Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
    J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
    Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
    Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.
    Korff T; Kimmina S; Martiny-Baron G; Augustin HG
    FASEB J; 2001 Feb; 15(2):447-57. PubMed ID: 11156960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.
    Griffioen AW; Coenen MJ; Damen CA; Hellwig SM; van Weering DH; Vooys W; Blijham GH; Groenewegen G
    Blood; 1997 Aug; 90(3):1150-9. PubMed ID: 9242547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
    Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
    Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue.
    Erzurum VZ; Bian JF; Husak VA; Ellinger J; Xue L; Burgess WH; Greisler HP
    J Vasc Surg; 2003 May; 37(5):1075-81. PubMed ID: 12756357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-derived endothelial cell growth factor inhibits DNA synthesis in vascular smooth muscle cells.
    Somjen D; Jaffe A; Knoll E; Kohen F; Amir-Zaltsman Y; Stern N
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):882-9. PubMed ID: 10509545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin.
    McDonald JR; Ong M; Shen C; Parandoosh Z; Sosnowski B; Bussell S; Houston LL
    Protein Expr Purif; 1996 Aug; 8(1):97-108. PubMed ID: 8812840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
    Lappi DA; Ying W; Barthelemy I; Martineau D; Prieto I; Benatti L; Soria M; Baird A
    J Biol Chem; 1994 Apr; 269(17):12552-8. PubMed ID: 8175664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U-61,431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells.
    Shirotani M; Yui Y; Hattori R; Kawai C
    Prostaglandins; 1991 Feb; 41(2):97-110. PubMed ID: 1708156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and chemical characterization of basic FGF-saporin mitotoxin.
    Lappi DA; Martineau D; Baird A
    Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
    Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
    Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic effects of FGF2-saporin on bovine epithelial lens cells in vitro.
    Behar-Cohen FF; David T; Buechler Y; Nova MP; Houston LL; Pouliquen YM; Courtois Y
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2425-33. PubMed ID: 7591632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.
    Yang Z; Kozai T; van der Loo B; Viswambharan H; Lachat M; Turina MI; Malinski T; Lüscher TF
    J Am Coll Cardiol; 2000 Nov; 36(5):1691-7. PubMed ID: 11079678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
    Buechler YJ; Sosnowski BA; Victor KD; Parandoosh Z; Bussell SJ; Shen C; Ryder M; Houston LL
    Eur J Biochem; 1995 Dec; 234(3):706-13. PubMed ID: 8575426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: characterizing and circumventing mechanisms of tumor resistance.
    Davol PA; Frackelton AR
    Prostate; 1999 Aug; 40(3):178-91. PubMed ID: 10398280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.